1-16 of 16
Andrius Žucenka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detection of B Cell Lymphomas By a Simple Epigenetic Blood Test

Irit Mazza Avivi, Miriam Neaman, Noa Lowenton-Spier, Chava Perry, Erel Joffe, Roy Vitkon, Vlada Bogol, Yael Michaeli, Noa Gilat, Lynne Itelson, Shahar Zirkin, Jasline Deek, Efstathios Kastritis, Karolis Sablauskas, Skirmante Cernauskiene, Vilmantė Vaitekėnaitė, Andrius Zucenka, Tomas Papajik, Eva Kriegova, Petr Gajdos, Yuval Ebenstein
Journal: Blood
Blood (2024) 144 (Supplement 1): 1582.
https://doi.org/10.1182/blood-2024-207707
Published: 2024
Journal Articles

Incorporating TET2 Variant Allele Frequency Enhances Prognostication in CMML: Insights from 849 Patients across Multiple Institutions

Yu-Hung Wang, Dorothée Selimoglu-Buet, Carmelo Gurnari, Andres Jerez, Andrius Zucenka, Chi-Yuan Yao, Chien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Jaroslaw Maciejewski, Eric Solary, Kiran Batta, Daniel H Wiseman
Journal: Blood
Blood (2024) 144 (Supplement 1): 4579.
https://doi.org/10.1182/blood-2024-194319
Published: 2024
Journal Articles

Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients with Chromosome 5 and 7 Abnormalities

Leora Boussi, Jan Philipp Bewersdorf, Yiwen Liu, Rory M. Shallis, Luis E. Aguirre, Andrius Zucenka, Sylvain Garciaz, Rebecca P. Bystrom, Daniel J. DeAngelo, Richard M Stone, Marlise R. Luskin, Jacqueline S. Garcia, Eric S. Winer, Evan Chen, Martha Wadleigh, Kelly Ling, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Shai O. Shimony, Maximilian Stahl
Journal: Blood
Blood (2024) 144 (Supplement 1): 4281.
https://doi.org/10.1182/blood-2024-204467
Published: 2024
Journal Articles

The Prognostic and Predictive Value of RUNX1 Mutations in Newly Diagnosed Acute Myeloid Leukemia - an International Multicenter Cohort Study

Rebecca P. Bystrom, Jan Philipp Bewersdorf, Yiwen Liu, Eva Johanna Schaefer, Rory M. Shallis, Leora Boussi, Andrius Zucenka, Sylvain Garciaz, Luis E. Aguirre, Daniel J. DeAngelo, Richard M. Stone, Marlise R. Luskin, Jacqueline S. Garcia, Eric S. Winer, Evan C. Chen, Martha Wadleigh, Kelly Ling, Eytan M. Stein, Aaron D. Goldberg, Amer M. Zeidan, Shai O. Shimony, Maximilian Stahl
Journal: Blood
Blood (2024) 144 (Supplement 1): 2947.
https://doi.org/10.1182/blood-2024-205581
Published: 2024
Journal Articles

Comparative Analysis of Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients Harboring Very-High Risk Cytogenetics

Luis E. Aguirre, Jan Philipp Bewersdorf, Yiwen Liu, Rory M. Shallis, Leora Boussi, Andrius Zucenka, Sylvain Garciaz, Rebecca P. Bystrom, Daniel J. DeAngelo, Richard M. Stone, Marlise R. Luskin, Jacqueline S. Garcia, Eric S. Winer, Kelly Ling, Evan C. Chen, Martha Wadleigh, Eytan M. Stein, Aaron D. Goldberg, Amer M. Zeidan, Shai O. Shimony, Maximilian Stahl
Journal: Blood
Blood (2024) 144 (Supplement 1): 4267.
https://doi.org/10.1182/blood-2024-202744
Published: 2024
Journal Articles

Venetoclax-Based Therapy Versus Intensive Chemotherapy Followed By Allogeneic-Stem Cell Transplantation for High-Risk Elderly Acute Myeloid Leukemia

Alexandre Iat, Jan Philipp Bewersdorf, Julia Gilhodes, Yiwen Liu, Rory M. Shallis, Leora Boussi, Andrius Zucenka, Rebecca P. Bystrom, Daniel J. DeAngelo, Guillaume Berton, Amel Soua, Kelly Ling, Luis E. Aguirre, Richard M Stone, Marlise R. Luskin, Jacqueline S. Garcia, Eric S. Winer, Evan C. Chen, Martha Wadleigh, Aaron D. Goldberg, Amer M. Zeidan, Thomas Cluzeau, Shai O. Shimony, Maximilian Stahl, Sylvain Garciaz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1508.
https://doi.org/10.1182/blood-2024-207045
Published: 2024
Journal Articles

Targeted, Low Cost Epigenetic Microarray for AML and MDS Detection

Miriam Neaman, Mika Bell, Jasline Deek, Rita Haldar, Amit Manor, Yakir Moshe, Irit Mazza Avivi, Moshe Mittelman, Roy Vitkon, Mor Levi, Roi Gat, Gil Fridberg, Natalia Birov, Guoda Daukėlaitė, Karolis Sablauskas, Andrejus Černovas, Andrius Zucenka, Vilmantė Vaitekėnaitė, Efstathios Kastritis, Tomas Papajik, Eva Kriegova, Martin Cernan, Tereza Dyskova, Yuval Ebenstein
Journal: Blood
Blood (2024) 144 (Supplement 1): 6142.
https://doi.org/10.1182/blood-2024-208540
Published: 2024
Journal Articles

Individualized Sequential Allogeneic Stem Cell Transplantation for Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Patients with Active Disease

Andrius Zucenka, Lukas Kevličius, Tautvilė Smalinskaitė, Guoda Daukėlaitė, Linas Davainis, Igoris Trociukas, Artūras Slobinas, Renata Jucaitienė, Inga Šlepikienė, Rita Čekauskienė, Vaida Jaraminė, Justė Strumskytė, Artūras Jakubauskas, Laimonas Griškevičius
Journal: Blood
Blood (2024) 144 (Supplement 1): 3487.
https://doi.org/10.1182/blood-2024-203229
Published: 2024
Journal Articles

Frontline Sequential Allogeneic Stem Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia with 3q26.2/ Mecom Rearrangement

Andrius Žučenka, Lukas Kevličius, Linas Davainis, Igoris Trociukas, Rita Čekauskienė, Vaida Jaraminė, Justė Strumskytė, Raminta Batiuškaitė, Rimvydas Norvilas, Vilma Valčeckienė, Vaidas Dirsė, Eglė Gineikienė-Valentinė, Artūras Jakubauskas, Laimonas Griškevičius
Journal: Blood
Blood (2024) 144 (Supplement 1): 7319.
https://doi.org/10.1182/blood-2024-208585
Published: 2024
Journal Articles

Updated Results and Longer Follow-up from the AUGMENT-101 Phase 2 Study of Revumenib in All Patients with Relapsed or Refractory (R/R) KMT2Ar Acute Leukemia

Ibrahim Aldoss, Ghayas C. Issa, James S. Blachly, Michael J. Thirman, Gabriel N Mannis, Martha L. Arellano, John F. DiPersio, Elie Traer, C. Michel Zwaan, Neerav Shukla, Branko Cuglievan, Carolyn S. Grove, Matthew Greenwood, Christine M. McMahon, Alexander E. Perl, Richard M. Stone, Cristina Papayannidis, David S. Dickens, Maël Heiblig, Andrius Žučenka, Pau Montesinos, Ioannis Mantzaris, Tibor Kovacsovics, Paul J. Shami, Li Yu, Rebecca G. Bagley, Nicole McNeer, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 211.
https://doi.org/10.1182/blood-2024-194384
Published: 2024
Journal Articles

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Yu-Hung Wang, Carmelo Gurnari, Chao-Hung Wei, Hussein Awada, Chien-Chin Lin, Andrius Zucenka, Chi-Yuan Yao, Kristian Gurashi, Hsin-An Hou, Kiran Batta, Wen-Chien Chou, Jaroslaw P. Maciejewski, Daniel H Wiseman, Hwei-Fang Tien
Journal: Blood
Blood (2023) 142 (Supplement 1): 627.
https://doi.org/10.1182/blood-2023-179907
Published: 2023
Journal Articles

Real-World Comparison of Venetoclax-Based Treatment Versus Intensive Chemotherapy As Bridging to Allogeneic Stem Cell Transplantation in MDS-IB2 Patients

Andrius Zucenka, Birutė Davainienė, Vilmantė Vaitekėnaitė, Rūta Čepulytė, Linas Davainis, Guoda Daukėlaitė, Lukas Kevličius, Regina Pileckytė, Igoris Trociukas, Laimonas Griškevičius
Journal: Blood
Blood (2023) 142 (Supplement 1): 6474.
https://doi.org/10.1182/blood-2023-178611
Published: 2023
Journal Articles

Revumenib Maintenance Therapy Following Revumenib-Induced Remission and Transplant

Andrius Zucenka, Ghayas C. Issa, Martha Arellano, Sajad Khazal, Nandita Khera, Wendy Stock, Branko Cuglievan, Yu Gu, Huy Van Nguyen, Angela R. Smith, Eytan M. Stein
Journal: Blood
Blood (2023) 142 (Supplement 1): 4950.
https://doi.org/10.1182/blood-2023-189036
Published: 2023
Journal Articles

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience

Ghayas C. Issa, Branko Cuglievan, Eytan Stein, Martha L. Arellano, Andrius Žucenka, Nandita Khera, Richard M. Stone, Michael J. Thirman, John F. DiPersio, Nicole Karras, Yu Gu, Rebecca G. Bagley, Galit Rosen, David Tamang, Kimberly Dishman, Sushama Scalera, Michael L. Meyers, Kate Madigan, Nicole McNeer, Ibrahim Aldoss
Journal: Blood
Blood (2022) 140 (Supplement 1): 914–916.
https://doi.org/10.1182/blood-2022-164600
Published: 2022
Journal Articles

Venetoclax-Based Therapies for Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2 in Clinical Practice Setting

Andrius Žucenka, Lukas Kevličius, Linas Davainis, Birutė Davainienė, Kazimieras Maneikis, Regina Pileckytė, Dominika Vasilevska, Igoris Trociukas, Vilmantė Vaitekėnaitė, Laimonas Griškevičius
Journal: Blood
Blood (2022) 140 (Supplement 1): 3358–3359.
https://doi.org/10.1182/blood-2022-165459
Published: 2022
Journal Articles

Venetoclax, Actinomycin D and Low Dose Cytarabine for Relapsed or Refractory Acute Myeloid Leukemia in Clinical Practice Setting

Andrius Zucenka, Vilmantė Vaitekėnaitė, Kazimieras Maneikis, Regina Pileckytė, Igoris Trociukas, Valdas Pečeliūnas, Laimonas Griškevičius
Journal: Blood
Blood (2021) 138 (Supplement 1): 3422.
https://doi.org/10.1182/blood-2021-144434
Published: 2021